Rivastigmine transdermal patch
CENA713DAU01
Approved small_molecule completed
Quick answer
Rivastigmine transdermal patch for Alzheimer's Disease is a Approved program (small_molecule) at Novartis Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novartis Pharmaceuticals
- Indication
- Alzheimer's Disease
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed